dihexa safety concerns hgf c-met cancer risk 10-K Targeting c-MET Alterations in Cancer:
Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications PMC Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Targeting the HGF c MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis British Journal of Cancer What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use?
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13


